Published in Br J Pharmacol on April 30, 2007
Obesity enhances eosinophilic inflammation in a murine model of allergic asthma. Br J Pharmacol (2010) 1.18
Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A (2009) 1.00
Regulation of G-protein-coupled signaling pathways in allergic inflammation. Immunol Res (2009) 0.94
Regulation of eosinophil trafficking by SWAP-70 and its role in allergic airway inflammation. J Immunol (2011) 0.90
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology (2011) 0.90
Asthma from a pharmacogenomic point of view. Br J Pharmacol (2008) 0.89
Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9. Immunogenetics (2010) 0.88
Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties. Int J Nanomedicine (2014) 0.87
The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages. Br J Pharmacol (2010) 0.85
Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models. FEBS J (2013) 0.83
Cytokines in chronic respiratory diseases. F1000 Biol Rep (2013) 0.81
Preventative effect of an herbal preparation (HemoHIM) on development of airway inflammation in mice via modulation of Th1/2 cells differentiation. PLoS One (2013) 0.80
The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes. Br J Pharmacol (2009) 0.80
Airway smooth muscle chemokine receptor expression and function in asthma. Clin Exp Allergy (2009) 0.80
Rare aggressive natural killer cell leukemia presented with bone marrow fibrosis - a diagnostic challenge. Springerplus (2014) 0.79
Perinatal bisphenol A exposure beginning before gestation enhances allergen sensitization, but not pulmonary inflammation, in adult mice. J Dev Orig Health Dis (2014) 0.76
Anti‑inflammatory effects of dihydromyricetin in a mouse model of asthma. Mol Med Rep (2017) 0.75
Chemokines: a new classification system and their role in immunity. Immunity (2000) 13.03
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med (1992) 11.90
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet (2002) 8.57
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest (2004) 7.91
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol (1994) 6.82
Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52
CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med (2006) 5.89
The global burden of asthma. Chest (2006) 5.74
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med (1999) 4.75
Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol (2003) 4.69
Eosinophilia. N Engl J Med (1998) 4.14
Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med (1999) 3.84
Interleukin-5, eosinophils, and disease. Blood (1992) 3.80
Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol (2001) 3.76
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis (1988) 3.45
A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol (2000) 3.44
Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med (2003) 3.34
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Non-eosinophilic corticosteroid unresponsive asthma. Lancet (1999) 3.25
Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest (2001) 3.19
CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A (1999) 3.00
Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol (2003) 2.95
Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med (2004) 2.93
IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol (1992) 2.89
Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol (1995) 2.88
Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest (2001) 2.87
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 2.83
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73
Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis (1993) 2.69
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax (2002) 2.63
The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol (2006) 2.35
Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med (2001) 2.34
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32
The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A (2002) 2.24
Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14
Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. Am J Respir Crit Care Med (2000) 2.06
Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol (2003) 2.06
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest (2001) 2.05
Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest (1999) 2.05
CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med (2002) 2.00
The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med (2005) 1.95
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med (1996) 1.93
TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol (2002) 1.92
Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol (1990) 1.88
Severe asthma in adults. Am J Respir Crit Care Med (2005) 1.74
CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest (2002) 1.73
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol (2001) 1.67
Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol (1996) 1.66
Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol (2001) 1.65
Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol (1995) 1.64
The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J (2006) 1.62
Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol (1991) 1.60
Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest (1991) 1.60
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol (1997) 1.59
Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med (2006) 1.53
Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis (1988) 1.52
Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. Br Med J (Clin Res Ed) (1985) 1.49
Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J Immunol (1998) 1.45
Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc Natl Acad Sci U S A (2005) 1.43
Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax (2006) 1.39
Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett (2003) 1.38
Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol (1999) 1.38
Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax (2002) 1.35
Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. J Allergy Clin Immunol (1999) 1.33
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol (1999) 1.33
How do corticosteroids work in asthma? Ann Intern Med (2003) 1.29
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. J Immunol (2002) 1.27
Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol (1997) 1.24
Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy (2005) 1.22
Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3. J Exp Med (2001) 1.22
CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease. J Immunol (2003) 1.21
Absence of CCR8 does not impair the response to ovalbumin-induced allergic airway disease. J Immunol (2003) 1.19
Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol (2004) 1.19
Invariant natural killer T cells in bronchial asthma. N Engl J Med (2006) 1.19
Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice. FASEB J (2002) 1.19
Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev (2005) 1.19
A theoretical analysis of the effect of airway smooth muscle load on airway narrowing. Am J Respir Crit Care Med (1996) 1.18
The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells. J Allergy Clin Immunol (2004) 1.15
Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J Leukoc Biol (2005) 1.14
Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol (1996) 1.14
IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4. J Allergy Clin Immunol (2005) 1.13
Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern Med (1997) 1.13
Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. Am Rev Respir Dis (1990) 1.12
Chemokine regulation of naïve T cell traffic in health and disease. Semin Immunol (2003) 1.11
Resting and activation-dependent ion channels in human mast cells. J Immunol (2001) 1.10
Retracted V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J Immunol (2005) 1.10
Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest (1987) 1.10
CD11/CD18-dependent and -independent neutrophil emigration in the lungs: how do neutrophils know which route to take? Am J Respir Cell Mol Biol (2000) 1.10
The inflammation-repair cycle in asthma: the pivotal role of the airway epithelium. Clin Exp Allergy (1998) 1.08
Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol (2000) 1.08
Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J Immunol (2002) 1.07
Receptor dimerization: a key step in chemokine signaling. Cell Mol Biol (Noisy-le-grand) (2001) 1.05
The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol (2000) 1.04
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest (1991) 3.88
Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med (1999) 3.84
Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis (1990) 3.70
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63
Non-eosinophilic corticosteroid unresponsive asthma. Lancet (1999) 3.25
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis (1989) 3.06
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J (2007) 2.78
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax (2002) 2.63
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ (1992) 2.25
Respiratory medicine: fighting for survival. BMJ (1992) 2.15
IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology (1990) 1.85
Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J (2000) 1.81
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax (2005) 1.81
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J (2009) 1.80
Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax (2003) 1.75
Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J (2005) 1.74
Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J Immunol (1991) 1.67
Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol (2001) 1.67
Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med (1991) 1.64
New insights into the role of the mast cell in asthma. Clin Exp Allergy (2003) 1.61
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood (1992) 1.59
The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J (1999) 1.58
The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy (2005) 1.52
Expression of CCR8 is increased in asthma. Clin Exp Allergy (2010) 1.51
New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond) (2002) 1.47
Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax (2006) 1.39
Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy (2003) 1.37
Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med (2001) 1.31
Adhesion to fibronectin prolongs eosinophil survival. J Exp Med (1993) 1.25
Adhesion of human lung mast cells to bronchial epithelium: evidence for a novel carbohydrate-mediated mechanism. J Leukoc Biol (2000) 1.24
Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med (1999) 1.24
Transfection of cells from patients with leukocyte adhesion deficiency with an integrin beta subunit (CD18) restores lymphocyte function-associated antigen-1 expression and function. J Clin Invest (1990) 1.24
Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy (2005) 1.22
Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax (2003) 1.19
Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med (1994) 1.17
Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med (2000) 1.15
Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol (1993) 1.14
Human mast cells express stem cell factor. J Pathol (1998) 1.12
Resting and activation-dependent ion channels in human mast cells. J Immunol (2001) 1.10
IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol (1995) 1.08
Effects of nedocromil sodium (Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells. Allergy (1988) 1.07
Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood (2000) 1.07
Structure and regulation of the leukocyte adhesion receptor LFA-1 and its counterreceptors, ICAM-1 and ICAM-2. Cold Spring Harb Symp Quant Biol (1989) 1.07
Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression. Allergy (2006) 1.02
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol (1996) 1.02
Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax (2006) 1.01
Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy (2005) 1.01
Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol (1985) (1988) 1.01
A case of cough, lymphocytic bronchoalveolitis and coeliac disease with improvement following a gluten free diet. Thorax (2002) 1.00
Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J (2005) 0.99
IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. J Immunol (1992) 0.99
Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol (2009) 0.99
CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology (1993) 0.98
Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophils. Blood (2001) 0.98
The combined effects of two pairs of mediators, adenosine with methacholine and prostaglandin D2 with histamine, on airway calibre in asthma. Clin Sci (Lond) (1986) 0.98
Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis. Allergy (1985) 0.96
Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Thorax (1996) 0.96
Morphological and secretory properties of bronchoalveolar lavage mast cells in respiratory diseases. Clin Allergy (1986) 0.96
Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. Eur Respir J (1999) 0.95
Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. Immunology (1996) 0.95
A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J Immunol Methods (1998) 0.95
Mechanisms of T cell migration to the lung. Clin Exp Allergy (2005) 0.94
Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy (1993) 0.93
Multiple inflammatory hits and the pathogenesis of severe airway disease. Eur Respir J (2006) 0.93
Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). Immunology (1994) 0.93
Expression of Bcl-2 and its homologues in human eosinophils. Modulation by interleukin-5. Am J Respir Cell Mol Biol (1999) 0.92
The safety and success rate of sputum induction using a low output ultrasonic nebuliser. Respir Med (1999) 0.92
A novel method for isolation of human lung T cells from lung resection tissue reveals increased expression of GAPDH and CXCR6. J Immunol Methods (2009) 0.90
The role of the eosinophil in the pathogenesis of asthma. Allergy (1987) 0.90
CRTH2 expression on T cells in asthma. Clin Exp Immunol (2010) 0.90
Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy (2012) 0.89
Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy (2010) 0.89
Between-observer repeatability of sputum differential cell counts. Influence of cell viability and squamous cell contamination. Clin Exp Allergy (1999) 0.89
Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteers. Clin Allergy (1988) 0.89
Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood (1996) 0.89
Management of asthma in adults: current therapy and future directions. Postgrad Med J (2003) 0.88
Cytokine production by human mast cells. Chem Immunol (1995) 0.87
Characterisation of adhesion receptors mediating lymphocyte adhesion to bronchial endothelium provides evidence for a distinct lung homing pathway. Thorax (2002) 0.87
Airway smooth muscle proliferation and survival is not modulated by mast cells. Clin Exp Allergy (2009) 0.87
Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. J Allergy Clin Immunol (1989) 0.87
Functional and structural characterization of the eosinophil P-selectin ligand. J Immunol (1996) 0.86
The airway smooth muscle CCR3/CCL11 axis is inhibited by mast cells. Allergy (2008) 0.85
Mucosal inflammation and asthma. Am J Respir Crit Care Med (1994) 0.85
The role of mast cells in the structural alterations of the airways as a potential mechanism in the pathogenesis of severe asthma. Curr Pharm Des (2011) 0.84
Co-cultivation of mast cells and Fc epsilon RI alpha+ dendritic-like cells from human hip bone marrow. Clin Exp Allergy (2005) 0.84
Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone. Immunology (1992) 0.84
Mepolizumab in refractory eosinophilic asthma. Thorax (2010) 0.84
Mucosal inflammation in severe glucocorticoid-dependent asthma. Eur Respir J (1999) 0.84
Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry. Thorax (1999) 0.83
Oesophageal obstruction during nasogastric feeding. Intensive Care Med (1991) 0.83